Orexigen gets allowance from USPTO for new US patent for Contrave
The patent is expected to expire in March of 2028. Orexigen expects the patent to be listed in the Orange Book maintained by the United States Food and
The patent is expected to expire in March of 2028. Orexigen expects the patent to be listed in the Orange Book maintained by the United States Food and
The European Commission will review the opinions and make a final decision sometime in the first quarter of 2015. "The CHMP positive opinions mark an important milestone in
Dr. Reddy’s ANDA is approved by the United States Food & Drug Administration (USFDA). The Allegra-D 12 Hour brand has U.S. sales of approximately $49.8 million for the
As part of the acquisition agreement, Apellis obtained the necessary intellectual property rights to develop its complement inhibitor drug compound (APL-2) in ophthalmology and plans its first clinical
The Notice of Allowance is for U.S. Patent Application No. 14/230,053, "Compositions for Treatment of Attention Deficit Hyperactivity Disorder" owned by Highland’s wholly owned subsidiary, Ironshore Pharmaceuticals &
The grant, with additional funding from Heptares, will support a three-year research project aimed at developing first-in-class, selective and orally available small molecule GLP-1 receptor antagonists for the
The inability to detect this overpouch mislabeling at the point of care may result in the administration of a dose lower than intended. In thehigh-risk patient population –
Produced using proprietary technology, Nagase’s unnatural amino acids are unique chiral building blocks for small molecule and peptide synthesis and can help overcome challenges in designing next-generation drug
Published in the November edition of the Drug Information Association’s Therapeutic Innovation & Regulatory Science (TIRS) journal, the results of the analysis support the TransCelerate-proposed methodology for risk-based
Biologic medicines are produced in living cells and the new Tuas facility encompasses multiple technologies to enable greater speed, productivity and flexibility in commercial-scale manufacturing. Built in less